| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jan 25 | NAMS NewAmsterdam Pharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 6,960 | 0.00 | 6,960 |
| 6 Jan 25 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 25.85 | 32,500 | 840.13 k | 32,500 |
| 12 Dec 24 | APGE Apogee Therapeutics | Common Stock | Buy | Acquire P | No | No | 49.85 | 12,500 | 623.13 k | 20,000 |
| 12 Dec 24 | APGE Apogee Therapeutics | Common Stock | Buy | Acquire P | No | No | 49.02 | 7,500 | 367.65 k | 7,500 |
| 17 Jul 24 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 18.81 | 72,500 | 1.36 mm | 72,500 |
